Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C19H17NO4 |
Molecular Weight | 323.3426 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12CC3=CC=C4OCOC4=C3CN1CCC5=CC6=C(OCO6)C=C25
InChI
InChIKey=UXYJCYXWJGAKQY-OAHLLOKOSA-N
InChI=1S/C19H17NO4/c1-2-16-19(24-10-21-16)14-8-20-4-3-12-6-17-18(23-9-22-17)7-13(12)15(20)5-11(1)14/h1-2,6-7,15H,3-5,8-10H2/t15-/m1/s1
Stylopine is a major component of the leaf of Chelidonium majus L. (Papaveraceae) which has been used for the removal of warts, papillomas, and condylomas, as well as the treatment of liver disease in oriental countries. It was shown that stylopine might contribute to the anti-inflammatory activity of Chelidonium majus by means of suppressing NO and PGE2 production. Stylopine has also been highlighted as a model compound for the design and future development of structurally related AKR1C3 inhibitors.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P42330|||Q9UII3 Gene ID: 8644.0 Gene Symbol: AKR1C3 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/24769118 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27387398
Different doses of aerial parts of F. capreolata (AFC) (25, 50 and 100mg/kg) were assayed in the DNBS model of experimental colitis in mice, and the colonic damage was evaluated both histologically and biochemically. AFC containS 1.3% of stylopine and 0.9% of protopine
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15473662
Curator's Comment: Stylopine per se had no cytotoxic effect in unstimulated RAW 264.7 cells, but concentration-dependently reduced nitric oxide (NO), prostaglandin E2 (PGE2), tumor necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta), and the IL-6 production and cyclooxygenase-2 (COX-2) activity caused by the LPS stimulation.
Unknown
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
J0JS75Q12Z
Created by
admin on Sat Dec 16 07:32:21 GMT 2023 , Edited by admin on Sat Dec 16 07:32:21 GMT 2023
|
PRIMARY | |||
|
m10258
Created by
admin on Sat Dec 16 07:32:21 GMT 2023 , Edited by admin on Sat Dec 16 07:32:21 GMT 2023
|
PRIMARY | |||
|
84-39-9
Created by
admin on Sat Dec 16 07:32:21 GMT 2023 , Edited by admin on Sat Dec 16 07:32:21 GMT 2023
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
18285
Created by
admin on Sat Dec 16 07:32:21 GMT 2023 , Edited by admin on Sat Dec 16 07:32:21 GMT 2023
|
PRIMARY | |||
|
697545
Created by
admin on Sat Dec 16 07:32:21 GMT 2023 , Edited by admin on Sat Dec 16 07:32:21 GMT 2023
|
PRIMARY | |||
|
110382
Created by
admin on Sat Dec 16 07:32:21 GMT 2023 , Edited by admin on Sat Dec 16 07:32:21 GMT 2023
|
PRIMARY | |||
|
Tetrahydrocoptisine
Created by
admin on Sat Dec 16 07:32:21 GMT 2023 , Edited by admin on Sat Dec 16 07:32:21 GMT 2023
|
PRIMARY | |||
|
4312-32-7
Created by
admin on Sat Dec 16 07:32:21 GMT 2023 , Edited by admin on Sat Dec 16 07:32:21 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD